The Penicillins and Streptomycins market in Malaysia has experienced significant growth from 2013 to 2023. By 2023, the market stood at $62.268 million, showing consistent year-on-year increases, particularly in 2018 with a 19.8% rise. The highest CAGR within the last decade was noted in 2015 at 16.96%, while recent growth slowed to a CAGR of 7.89% in 2023.

Future trends to watch for include:

An anticipated average growth rate of 4.52% per year over the next five years.
Expected overall growth rate of 24.76% from 2024 to 2028.
Possible impact of regulatory changes and healthcare policies on market dynamics.
Technological innovations and advancements in antibiotic formulation and delivery.